期刊文献+

基于NLRP3炎症小体探讨中医药防治溃疡性结肠炎的机制 被引量:11

Mechanism of Chinese herbal medicine treatment of ulcerative colitis via nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome
原文传递
导出
摘要 溃疡性结肠炎(ulcerative colitis,UC)是一种病因不明、易反复的慢性非特异性肠道疾病[1],其增加结直肠癌的风险已被证实[2]。近期Ola Olén团队在柳叶刀上发表的研究表明,UC患者结直肠癌的发病率和死亡率显著高于非UC患者[3],严重威胁着人们的生命健康。目前,氨基水杨酸类、皮质类固醇和免疫抑制剂等为轻、重度UC的治疗药物。一般认为UC的潜在发病机制为:免疫介导的慢性肠道非可控性炎症,导致肠黏膜屏障损伤。 Ulcerative colitis(UC) is an unexplained, recurrent,chronic nonspecific intestinal disease,and chronic colitis has been shown to increase the risk of colorectal cancer.Many studies have reported that nucleotide-binding oligomerization domain-like receptor protein 3(NLRP3)inflammasome is closely related to the development of UC.Therefore,NLRP3 inflammasome are likely to become a new target for the treatment of UC.Chinese herbal medicine has the characteristics of multi-target,multi-function and multi-pathway against inflammatory,cancer and immunological diseases.This review provides a further understanding of the key mechanisms of Traditional Chinese Medicine in the regulation of NLRP3 inflammasome and demonstrates new ideas and directions for treatment of UC.
作者 张海明 梁凤霞 杨胜兰 张君丽 袁昌劲 陈瑞 ZHANG Haiming;LIANG Fengxia;YANG ShengLan
出处 《中国中西医结合消化杂志》 CAS 2021年第7期524-528,共5页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
基金 国家自然科学基金面上项目(No:81774401,No:81774420,No:81874397,No:81900520) 武汉市中心医院院内科研基金(No:2017Y10)。
关键词 核苷酸结合寡聚化结构域样受体蛋白3 炎症小体 溃疡性结肠炎 结直肠癌 中医药 炎-癌转化 nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome ulcerative colitis colorectal cancer Traditional Chinese Medicine inflammation-cancer transformation
  • 相关文献

参考文献14

二级参考文献111

  • 1徐志刚.溃疡性结肠炎组织中TLR4、NF-κB p65 和SIGIRR的表达及意义[J].中文科技期刊数据库(文摘版)医药卫生,2016(9):277-277. 被引量:1
  • 2Xavier R J, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease [ J . Nature, 2007, 448 : 427-434.
  • 3Molodecky NA, Soon IS, Rabi DM, et al. Increasing inci- dence and prevalence of the inflammatory bowel diseases with time, based on systematic review [J]. Gastroenterolo- gy, 2012,142:46-54.
  • 4Chow DK, Leong RW, Tsoi KK, et al. Long-term follow-up of ulcerative colitis in the Chinese population [ J ]. Am J Gastroenterol, 2009,104:647-654.
  • 5Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increas- ing the number of confirmed associations to 47 [ J ]. Nat Genet, 2011,43:246-252.
  • 6Thompson AI, Lees CW. Genetics of ulcerative colitis [ J ]. Inflamm Bowel Dis, 2011,17 : 831- 848.
  • 7Shi J, Zhou L, Zhernakova A, et al. Haplotype-based anal- ysis of ulcerative colitis risk loci identifies both IL2 and IL21 as susceptibility genes in Han Chinese [ J]. Inflamm Bowel Dis, 2011,17:2472-2479.
  • 8Cummings JR, Cooney RM, Clarke G, et al. The genetics of NOD-like receptors in Crohn's disease [ J ]. Tissue Anti- gens, 2010, 76: 48-56.
  • 9Zhang HX, Wang ZT, Lu XX, et al. NLRP3 gene is asso- ciated with ulcerative colitis (UC) , but not Crohn's disease (CD), in Chinese Han population [ J ]. Inflamm Res, 2014,63:979-985.
  • 10Kummer JA, Broekhuizen R, Everett H, et al. Inflamma- some components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specif- ic role in the inflammatory response [ J ]. J Histochem Cy- tochem, 2007,55:443-452.

共引文献136

同被引文献154

引证文献11

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部